Latest News Archive
Please select Category, Year, and then Month to display items
16 February 2024
|
Story ANTHONY MTHEMBU
|
Photo ROSINA MOTHIBA
Prof Matseliso Mokhele-Makgalwa: Vice Dean; Research, Engagement and Internationalisation in the Faculty of Education at the University of the Free State (UFS).
The Faculty of Education at the University of the Free State (UFS) proudly announces the appointment of Prof Matseliso Mokhele-Makgalwa as Vice Dean of Research, Engagement and Internationalisation, effective 1 January 2024. With a wealth of experience and a fervent dedication to academic advancement, Prof Mokhele-Makgalwa’s appointment marks a significant stride towards enhancing the faculty’s global presence and academic prowess.
Transitioning into a new role
Transitioning seamlessly from her previous role as Acting Vice Dean of Research and Postgraduate Studies, Prof Mokhele-Makgalwa perceives this new appointment as a natural progression, elevating her responsibilities to spearhead research endeavours, foster engagement, and cultivate international partnerships within the faculty. Embracing this pivotal role with enthusiasm, she underscores the importance of collaborative efforts among faculty members, securing research funding, and ensuring the quality and impact of scholarly outputs.
“I appreciate the opportunity to contribute significantly to the faculty’s research, engagement and internalisation efforts,” says Prof Mokhele-Makgalwa. “I look forward to collaborating with the faculty staff members to advance our academic initiatives on a broader scale.”
A vision of progression for the faculty
At the heart of her vision lies a commitment to realise the UFS’s Vision130, wherein Prof Mokhele-Makgalwa aims to elevate the international profile of the faculty, foster impactful research, promote engaged scholarship, and facilitate knowledge exchange on a global scale. Her strategic objectives also include positioning the faculty among the top three education schools nationally, reflecting her dedication to academic excellence and institutional advancement.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”